日经225指数上涨1.03%,收于34730点,而更广泛的东证指数周五上涨1.14%,收于2559点,延续了前一交易日的涨幅,因为人们希望美日之间正在进行的贸易谈判将导致关税让步。本周早些时候,日本经济大臣赤泽龙成告诉记者,特朗普表示与日本达成协议是“首要任务”。在经济方面,新的数据显示,日本3月份的整体通胀率降至3.6%的四个月低点,而核心通胀率则如预期般加速至3.2%。展望未来,市场关注日本央行下周的政策会议。人们普遍预计,央行将把利率稳定在0.5%,并可能根据潜在的关税影响下调其增长前景。在企业新闻中,中外制药股价飙升17.5%,此前该公司与礼来公司共同开发的减肥药物显示出与Ozempic相似的性能。
The Nikkei 225 Index jumped 1.03% to close at 34,730 while the broader Topix Index rallied 1.14% to 2,559 on Friday, extending gains from the previous session amid hopes that ongoing trade talks between the US and Japan will lead to tariff concessions. Earlier this week, Japanese Economy Minister Ryosei Akazawa told reporters that Trump said getting a deal with Japan was a “top priority.” On the economic front, fresh data showed that Japan’s headline inflation eased to a four-month low of 3.6% in March, while core inflation accelerated as expected to 3.2%. Looking ahead, markets are focused on the Bank of Japan’s policy meeting next week. The central bank is widely expected to keep interest rates steady at 0.5% and may revise its growth outlook downward in light of potential tariff impacts. In corporate news, Chugai Pharmaceuticals surged 17.5% after the drug it developed with Eli Lilly for losing weight showed similar performance as Ozempic.